Home > Back to Publisher > Report Information

OTC Healthcare in Colombia to 2011

Datamonitor
August 5, 2008
197 Pages - SKU: DFMN1872838

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Colombia

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Colombia. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in Colombia increased between 2001-2006, growing at an average annual rate of 6.4%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was GlaxoSmithKline Plc with Tecnoquímicas SA in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

EXECUTIVE SUMMARY
: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
INTRODUCTION
: What is this report about?; How to use this report; Market Definition
MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
LEADING COMPANY PROFILES
: Pfizer Inc; GlaxoSmithKline Plc
CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
COUNTRY COMPARISON
: Value; Market Share
NEW PRODUCT DEVELOPMENT
: Product launches over time; Recent product launches
COLOMBIA SOCIOECONOMIC PROFILE
: Country Overview; Key Facts; Political Overview; Colombia Economic Overview
COLOMBIA MACROECONOMIC PROFILE
: Macroeconomic Indicators
RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
CHAPTER 20 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: Colombia OTC Healthcare value & value forecast, 2001-2011 (COP m, nominal prices); Figure 2: Colombia OTC Healthcare company share, by value, 2005-2006 (%); Figure 3: Colombia Analgesics value & value forecast, 2001-2011 (COP m, nominal prices); Figure 4: Colombia Analgesics category growth comparison, by value, 2001-2011; Figure 5: Colombia Analgesics company share, by value, 2005-2006 (%); Figure 6: Colombia Cough and Cold Preparations value & value forecast, 2001-2011 (COP m, nominal prices); Figure 7: Colombia Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 8: Colombia Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 9: Colombia Traditional Medicines value & value forecast, 2001-2011 (COP m, nominal prices); Figure 10: Colombia Traditional Medicines company share, by value, 2005-2006 (%); Figure 11: Colombia First Aid Kits value & value forecast, 2001-2011 (COP m, nominal prices); Figure 12: Colombia First Aid Kits company share, by value, 2005-2006 (%); Figure 13: Colombia Indigestion Preparations value & value forecast, 2001-2011 (COP m, nominal prices); Figure 14: Colombia Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 15: Colombia Indigestion Preparations company share, by value, 2005-2006 (%); Figure 16: Colombia Vitamins and Minerals value & value forecast, 2001-2011 (COP m, nominal prices); Figure 17: Colombia Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 18: Colombia Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 19: Colombia Plasters & Bandages value & value forecast, 2001-2011 (COP m, nominal prices); Figure 20: Colombia Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 21: Colombia Plasters & Bandages company share, by value, 2005-2006 (%); Figure 22: Colombia Medicated Skin Products value & value forecast, 2001-2011 (COP m, nominal prices); Figure 23: Colombia Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 24: Colombia Medicated Skin Products company share, by value, 2005-2006 (%); Figure 25: Colombia Other OTC Healthcare Products value & value forecast, 2001-2011 (COP m, nominal prices); Figure 26: Colombia Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 27: Colombia Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 28: Colombia Topical OTC Medicines value & value forecast, 2001-2011 (COP m, nominal prices); Figure 29: Colombia Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 30: Colombia Topical OTC Medicines company share, by value, 2005-2006 (%); Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 33: Map of Colombia; Figure 34: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: Colombia OTC Healthcare value, 2001-2006 (COP m, nominal prices); Table 3: Colombia OTC Healthcare value forecast, 2006-2011 (COP m, nominal prices); Table 4: Colombia OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: Colombia OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: Colombia OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: Colombia OTC Healthcare value, by brand 2005-2006 (COP m nominal prices); Table 8: Colombia OTC Healthcare company share by value, 2005-2006 (%); Table 9: Colombia OTC Healthcare value, by company, 2005-2006 (COP m nominal prices); Table 10: Colombia OTC Healthcare expenditure per capita, 2001-2006 (COP, nominal prices); Table 11: Colombia OTC Healthcare forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 12: Colombia OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: Colombia OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: Pfizer Inc Key Facts; Table 15: GlaxoSmithKline Key Facts; Table 16: Colombia Analgesics value, 2001-2006 (COP m, nominal prices); Table 17: Colombia Analgesics value forecast, 2006-2011 (COP m, nominal prices); Table 18: Colombia Analgesics value, 2001-2006 (US$ m nominal prices); Table 19: Colombia Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 20: Colombia Analgesics brand share, by value, 2005-2006 (%); Table 21: Colombia Analgesics value, by brand 2005-2006 (COP m nominal prices); Table 22: Colombia Analgesics company share by value, 2005-2006 (%); Table 23: Colombia Analgesics value, by company, 2005-2006 (COP m nominal prices); Table 24: Colombia Analgesics expenditure per capita, 2001-2006 (COP, nominal prices); Table 25: Colombia Analgesics forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 26: Colombia Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 27: Colombia Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 28: Colombia Cough and Cold Preparations value, 2001-2006 (COP m, nominal prices); Table 29: Colombia Cough and Cold Preparations value forecast, 2006-2011 (COP m, nominal prices); Table 30: Colombia Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 31: Colombia Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 32: Colombia Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 33: Colombia Cough and Cold Preparations value, by brand 2005-2006 (COP m nominal prices); Table 34: Colombia Cough and Cold Preparations company share by value, 2005-2006 (%); Table 35: Colombia Cough and Cold Preparations value, by company, 2005-2006 (COP m nominal prices); Table 36: Colombia Cough and Cold Preparations expenditure per capita, 2001-2006 (COP, nominal prices); Table 37: Colombia Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 38: Colombia Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 39: Colombia Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 40: Colombia Traditional Medicines value, 2001-2006 (COP m, nominal prices); Table 41: Colombia Traditional Medicines value forecast, 2006-2011 (COP m, nominal prices); Table 42: Colombia Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 43: Colombia Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 44: Colombia Traditional Medicines brand share, by value, 2005-2006 (%); Table 45: Colombia Traditional Medicines value, by brand 2005-2006 (COP m nominal prices); Table 46: Colombia Traditional Medicines company share by value, 2005-2006 (%); Table 47: Colombia Traditional Medicines value, by company, 2005-2006 (COP m nominal prices); Table 48: Colombia Traditional Medicines expenditure per capita, 2001-2006 (COP, nominal prices); Table 49: Colombia Traditional Medicines forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 50: Colombia Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 51: Colombia Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 52: Colombia First Aid Kits value, 2001-2006 (COP m, nominal prices); Table 53: Colombia First Aid Kits value forecast, 2006-2011 (COP m, nominal prices); Table 54: Colombia First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 55: Colombia First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 56: Colombia First Aid Kits brand share, by value, 2005-2006 (%); Table 57: Colombia First Aid Kits value, by brand 2005-2006 (COP m nominal prices); Table 58: Colombia First Aid Kits company share by value, 2005-2006 (%); Table 59: Colombia First Aid Kits value, by company, 2005-2006 (COP m nominal prices); Table 60: Colombia First Aid Kits expenditure per capita, 2001-2006 (COP, nominal prices); Table 61: Colombia First Aid Kits forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 62: Colombia First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 63: Colombia First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 64: Colombia Indigestion Preparations value, 2001-2006 (COP m, nominal prices); Table 65: Colombia Indigestion Preparations value forecast, 2006-2011 (COP m, nominal prices); Table 66: Colombia Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 67: Colombia Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 68: Colombia Indigestion Preparations brand share, by value, 2005-2006 (%); Table 69: Colombia Indigestion Preparations value, by brand 2005-2006 (COP m nominal prices); Table 70: Colombia Indigestion Preparations company share by value, 2005-2006 (%); Table 71: Colombia Indigestion Preparations value, by company, 2005-2006 (COP m nominal prices); Table 72: Colombia Indigestion Preparations expenditure per capita, 2001-2006 (COP, nominal prices); Table 73: Colombia Indigestion Preparations forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 74: Colombia Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 75: Colombia Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 76: Colombia Vitamins and Minerals value, 2001-2006 (COP m, nominal prices); Table 77: Colombia Vitamins and Minerals value forecast, 2006-2011 (COP m, nominal prices); Table 78: Colombia Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 79: Colombia Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 80: Colombia Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 81: Colombia Vitamins and Minerals value, by brand 2005-2006 (COP m nominal prices); Table 82: Colombia Vitamins and Minerals company share by value, 2005-2006 (%); Table 83: Colombia Vitamins and Minerals value, by company, 2005-2006 (COP m nominal prices); Table 84: Colombia Vitamins and Minerals expenditure per capita, 2001-2006 (COP, nominal prices); Table 85: Colombia Vitamins and Minerals forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 86: Colombia Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 87: Colombia Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 88: Colombia Plasters & Bandages value, 2001-2006 (COP m, nominal prices); Table 89: Colombia Plasters & Bandages value forecast, 2006-2011 (COP m, nominal prices); Table 90: Colombia Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 91: Colombia Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 92: Colombia Plasters & Bandages brand share, by value, 2005-2006 (%); Table 93: Colombia Plasters & Bandages value, by brand 2005-2006 (COP m nominal prices); Table 94: Colombia Plasters & Bandages company share by value, 2005-2006 (%); Table 95: Colombia Plasters & Bandages value, by company, 2005-2006 (COP m nominal prices); Table 96: Colombia Plasters & Bandages expenditure per capita, 2001-2006 (COP, nominal prices); Table 97: Colombia Plasters & Bandages forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 98: Colombia Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 99: Colombia Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 100: Colombia Medicated Skin Products value, 2001-2006 (COP m, nominal prices); Table 101: Colombia Medicated Skin Products value forecast, 2006-2011 (COP m, nominal prices); Table 102: Colombia Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 103: Colombia Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 104: Colombia Medicated Skin Products brand share, by value, 2005-2006 (%); Table 105: Colombia Medicated Skin Products value, by brand 2005-2006 (COP m nominal prices); Table 106: Colombia Medicated Skin Products company share by value, 2005-2006 (%); Table 107: Colombia Medicated Skin Products value, by company, 2005-2006 (COP m nominal prices); Table 108: Colombia Medicated Skin Products expenditure per capita, 2001-2006 (COP nominal prices); Table 109: Colombia Medicated Skin Products forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 110: Colombia Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 111: Colombia Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 112: Colombia Other OTC Healthcare Products value, 2001-2006 (COP m, nominal prices); Table 113: Colombia Other OTC Healthcare Products value forecast, 2006-2011 (COP m, nominal prices); Table 114: Colombia Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 115: Colombia Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 116: Colombia Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 117: Colombia Other OTC Healthcare Products value, by brand 2005-2006 (COP m nominal prices); Table 118: Colombia Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 119: Colombia Other OTC Healthcare Products value, by company, 2005-2006 (COP m nominal prices); Table 120: Colombia Other OTC Healthcare Products expenditure per capita, 2001-2006 (COP, nominal prices); Table 121: Colombia Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 122: Colombia Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 123: Colombia Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 124: Colombia Topical OTC Medicines value, 2001-2006 (COP m, nominal prices); Table 125: Colombia Topical OTC Medicines value forecast, 2006-2011 (COP m, nominal prices); Table 126: Colombia Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 127: Colombia Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 128: Colombia Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 129: Colombia Topical OTC Medicines value, by brand 2005-2006 (COP m nominal prices); Table 130: Colombia Topical OTC Medicines company share by value, 2005-2006 (%); Table 131: Colombia Topical OTC Medicines value, by company, 2005-2006 (COP m nominal prices); Table 132: Colombia Topical OTC Medicines expenditure per capita, 2001-2006 (COP, nominal prices); Table 133: Colombia Topical OTC Medicines forecast expenditure per capita, 2006-2011 (COP, nominal prices); Table 134: Colombia Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 135: Colombia Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 136: Global OTC Healthcare market value, 2006; Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 138: Leading players - Top 5 countries; Table 139: Colombia OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006; Table 140: Colombia OTC Healthcare new product launches (reports), by flavor and fragrances 2006; Table 141: Colombia OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006; Table 142: Colombia OTC Healthcare new product launches (reports), by Package tags or Claims 2006; Table 143: Colombia OTC Healthcare new product launches (reports) - Recent 5 launches; Table 144: Colombia Key Facts; Table 145: Colombia population, by age group, 2000-2005 (millions); Table 146: Colombia population forecast, by age group, 2005-2010 (millions); Table 147: Colombia real GDP, 2000-2005 (COP bn, 2005 prices); Table 148: Colombia real GDP forecast, 2005-2010 (COP bn, 2005 prices); Table 149: Colombia nominal GDP, 2000-2005 (COP bn, nominal prices); Table 150: Colombia real GDP, 2000-2005 (US$ bn, 2005 prices); Table 151: Colombia real GDP forecast, 2005-2010 (US$ bn, 2005 prices); Table 152: Colombia consumer price index, 2000-2005 (2000=100); Table 153: Colombia consumer price index, 2005-2010 (2000=100); Table 154: Colombia exchange rate, 2000-2005

More Colombia Over-the-Counter Drugs Reports

The Pharmaceutical Market: Colombia (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

Incontinence in Colombia by Euromonitor International
The Colombian population is ageing. In 2010 about 6% of the population (some 2.6 million people that represented almost 8% of the gross income of ...

Medicated Skin Care - Colombia by Euromonitor International
In Colombia not only women but also men are increasingly concerned about their skin not only for health concerns but also because they value their ...

Herbal/traditional Products - Colombia by Euromonitor International
Herbal/traditional remedies continue growing their sales in Colombia as their offerings continue increasing and more people are acknowledging their positive effects on human health, as ...

Ear Care - Colombia by Euromonitor International
Ear care accounted for sales of Col$260 million in 2009. This category continued showing slow growth as prescriptions continue being the driver of purchases; ears ...

See all reports like this >>

More Colombia Reports

D&B Country RiskLine Report: Colombia by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Colombia: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis of Colombia, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

D&B Country Report: Colombia by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

2007 Colombia Industry & Market Outlook report by Barnes Reports
The 2007 Colombia Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Colombia and 500+ minor industries ...

The Economic Competitiveness of Colombia: Financials Returns, Labor Productivity and International Gaps by Icon Group International, Inc.
Is Colombia competitive? With the globalization of markets, the increased mobility of corporate assets, and the need for productive human resources, this question has ...

See all reports like this >>

OTC Healthcare in Colombia to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service